We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,513 results
  1. Severe cardiac and skeletal manifestations in DMD-edited microminipigs: an advanced surrogate for Duchenne muscular dystrophy

    Duchenne muscular dystrophy (DMD) is an intractable X-linked muscular dystrophy caused by mutations in the DMD gene. While many animal models have...

    Masayoshi Otake, Michihiro Imamura, ... Yoshitsugu Aoki in Communications Biology
    Article Open access 03 May 2024
  2. The exon junction complex is required for DMD gene splicing fidelity and myogenic differentiation

    Deposition of the exon junction complex (EJC) upstream of exon-exon junctions helps maintain transcriptome integrity by preventing spurious...

    Dylan Da Cunha, Julie Miro, ... Sylvie Tuffery-Giraud in Cellular and Molecular Life Sciences
    Article Open access 21 March 2024
  3. IPSC derived cardiac fibroblasts of DMD patients show compromised actin microfilaments, metabolic shift and pro-fibrotic phenotype

    Duchenne muscular dystrophy (DMD) is a severe form of muscular dystrophy caused by mutations in the dystrophin gene. We characterized which isoforms...

    Salwa Soussi, Lesia Savchenko, ... Nathalie Pizzinat in Biology Direct
    Article Open access 27 July 2023
  4. In Vivo Evaluation of Exon 51 Skip** in hDMD/Dmd-null Mice

    Duchenne muscular dystrophy (DMD) is a fatal X-linked condition that affects 1 in 3500–6000 newborn boys a year. An out-of-frame mutation in the DMD...
    Narin Sheri, Toshifumi Yokota in Skeletal Muscle Stem Cells
    Protocol 2023
  5. Morpholino oligonucleotide-mediated exon skip** for DMD treatment: Past insights, present challenges and future perspectives

    Duchenne muscular dystrophy (DMD) is an X-linked genetic disease primarily affecting boys causing loss of the dystrophin protein, ultimately leading...

    Shalini Gupta, Swrajit Nath Sharma, ... Surajit Sinha in Journal of Biosciences
    Article 11 October 2023
  6. Exons 45–55 Skip** Using Antisense Oligonucleotides in Immortalized Human DMD Muscle Cells

    Antisense oligonucleotides (AOs) have demonstrated high potential as a therapy for treating genetic diseases like Duchene muscular dystrophy (DMD)....
    Merry He, Toshifumi Yokota in Skeletal Muscle Stem Cells
    Protocol 2023
  7. A microminipig model of DMD

    Alexandra Le Bras in Lab Animal
    Article 04 June 2024
  8. Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD

    Lack of dystrophin expression is the underlying genetic basis for Duchenne muscular dystrophy (DMD). However, disease severity varies between...

    Davi A. G. Mázala, Ravi Hindupur, ... Jyoti K. Jaiswal in Cell Death Discovery
    Article Open access 04 July 2023
  9. Comprehensive analysis of genomic complexity in the 5’ end coding region of the DMD gene in patients of exons 1–2 duplications based on long-read sequencing

    Background

    Dystrophinopathies are the most common X-linked inherited muscle diseases, and the disease-causing gene is DMD . Exonic duplications are a...

    Jiandong Shen, Taoli Ding, ... Feiyang Diao in BMC Genomics
    Article Open access 19 March 2024
  10. Pathological alterations in the gastrointestinal tract of a porcine model of DMD

    Background

    Patients with Duchenne muscular dystrophy (DMD) develop severe skeletal and cardiac muscle pathologies, which result in premature death....

    **aodong Zou, Hongsheng Ouyang, ... **aochun Tang in Cell & Bioscience
    Article Open access 15 July 2021
  11. Effect of parasitic infection on muscular function of dystrophin gene (Dmd) deficient mouse

    Background

    Previous studies have reported many cases of Trichinella spiralis ( T. spiralis ) infection in normal skeletal muscle but there is little...

    Ha Rim Shin, Eun-Ji Ko, ... Hee-Jae Cha in Genes & Genomics
    Article 26 December 2022
  12. A female carrier of a novel DMD mutation with slightly skewed X-chromosome inactivation shows a suspected case of Becker muscular dystrophy in a Chinese family

    Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are both caused by mutations in DMD gene effecting the expression of...

    Jianfan Chen, Hui Zheng, ... Fu **ong in Molecular Genetics and Genomics
    Article 10 February 2021
  13. Identification of two rare mutations c.1318G>A and c.6438+2T>G in a Chinese DMD family as genetic markers

    Background

    Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive disorder with no effective treatment, which underscores the importance of...

    Yingchuan Zhu, Lijun Yang, ... Yongxin Ma in Genes & Genomics
    Article 28 July 2020
  14. Patterned Optogenetic Stimulation Using a DMD Projector

    Optical manipulation is a powerful way to control neural activity in vitro and in vivo with millisecond precision. Patterning of light provides the...
    Aanchal Bhatia, Sahil Moza, Upinder S. Bhalla in Channelrhodopsin
    Protocol 2021
  15. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice

    Background

    Duchenne muscular dystrophy (DMD) is associated with impaired muscle regeneration, progressive muscle weakness, damage, and wasting. While...

    Emily Freeman, Stéphanie Langlois, ... Kyle N. Cowan in Skeletal Muscle
    Article Open access 26 April 2024
  16. N-terminal titin fragment: a non-invasive, pharmacodynamic biomarker for microdystrophin efficacy

    Background

    Multiple clinical trials to assess the efficacy of AAV-directed gene transfer in participants with Duchenne muscular dystrophy (DMD) are...

    Jessica F. Boehler, Kristy J. Brown, ... Carl A. Morris in Skeletal Muscle
    Article Open access 16 January 2024
  17. Replenishing NAD+ content reduces aspects of striated muscle disease in a dog model of Duchenne muscular dystrophy

    Duchenne muscular dystrophy (DMD) is an X-linked disease caused by mutations in DMD gene and loss of the protein dystrophin, which ultimately leads...

    Déborah Cardoso, Inès Barthélémy, ... Antoine Muchir in Skeletal Muscle
    Article Open access 04 December 2023
  18. Production of Duchenne muscular dystrophy cellular model using CRISPR-Cas9 exon deletion strategy

    Duchenne Muscular Dystrophy (DMD) is a progressive muscle wasting disorder caused by loss-of-function mutations in the dystrophin gene. Although the...

    Farzaneh Alizadeh, Yousef Jafari Abraghan, ... Majid Mojarrad in Molecular and Cellular Biochemistry
    Article 08 June 2023
  19. Cell Therapy Strategies on Duchenne Muscular Dystrophy: A Systematic Review of Clinical Applications

    Duchenne Muscular Dystrophy (DMD) is an inherited genetic disorder characterized by progressive degeneration of muscle tissue, leading to functional...

    Ayberk Akat, Erdal Karaöz in Stem Cell Reviews and Reports
    Article 13 November 2023
Did you find what you were looking for? Share feedback.